EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression

Paula González-López, Yinda Yu, Shiying Lin, Óscar Escribano, Almudena Gómez-Hernández, Anton Gisterå iD

Journal of Cardiovascular Translational Research · 2024

DOI: 10.1007/s12265-024-10482-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2024. Verfasst von Paula González-López und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: MicroRNAs, Disease Progression, Disease Models, Animal, Carotid Artery Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärt-Lungfonden, Åke Wiberg Stiftelse, Spanish Ministry of Science and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis commonly remains undiagnosed until disease manifestations occur. The disease is associated with dysregulated micro(mi)RNAs, but how this is linked to atherosclerosis-related immune reactions is largely unknown. A mouse model of carotid atherosclerosis, human APOB100 -transgenic Ldlr −/− (HuBL), was used to study the spatiotemporal dysregulation of a set of miRNAs. Middle-aged HuBL mice with established atherosclerosis had decreased levels of miR-143-3p in their carotid arteries. In young HuBL mice, early atherosclerosis was observed in the carotid bifurcation, which had lower levels of miR-15a-5p, miR-143-3p, and miR-199a-3p, and higher levels of miR-155-5p. The dysregulation of these miRNAs was reflected by specific immune responses during atheroprogression. Finally, levels of miR-143-3p were 70.6% lower in extracellular vesicles isolated from the plasma of patients with carotid stenosis compared to healthy controls. Since miR-143-3p levels progressively decrease when transitioning between early and late experimental carotid atherosclerosis, we propose it as a biomarker for atherosclerosis. Graphical Abstract Low levels of miR-143-3p in plasma extracellular vesicles can serve as a biomarker for atherosclerosis, and dysregulation of microRNAs is linked to the immune reactions associated with disease progression

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDisease ProgressionDisease Models, AnimalCarotid Artery DiseasesApolipoprotein B-100AnimalsHumansMaleFemaleCase-Control StudiesReceptors, LDLPlaque, AtheroscleroticCarotid ArteriesCarotid StenosisExtracellular VesiclesMice, KnockoutMiddle AgedBiomarkersMice, Inbred C57BLGene Expression RegulationMice, TransgenicGenetic Markers

Stichwörter der Autor:innen

AtherosclerosisCarotid stenosisDyslipidemiaMicro-RNAT-lymphocytes

Substanzen

MicroRNAsApolipoprotein B-100Receptors, LDLMIRN143 microRNA, humanBiomarkersAPOB protein, humanGenetic Markers

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
  • Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. anton.gistera@ki.se.
  • Bioclinicum J8:20, Karolinska University Hospital, Visionsgatan 4, Solna, SE-17164, Stockholm, Sweden. anton.gistera@ki.se.

ORCID-Profile: Anton Gisterå

Förderung

  • Hjärt-Lungfonden
  • Åke Wiberg Stiftelse
  • Spanish Ministry of Science and Innovation
  • Jeanssons Stiftelser
  • Gun och Bertil Stohnes Stiftelse
  • Foundation for Geriatric Diseases at Karolinska Institutet
  • Karolinska Institutet Research Foundation
  • Stiftelsen för Gamla Tjänarinnor

Zitieren

APA

González-López, P., Yu, Y., Lin, S., Escribano, Ó., Gómez-Hernández, A., & Gisterå, A. (2024). Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-024-10482-1

Vancouver

González-López P, Yu Y, Lin S, Escribano Ó, Gómez-Hernández A, Gisterå A. Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression. Journal of Cardiovascular Translational Research. 2024. doi:10.1007/s12265-024-10482-1

BibTeX
@article{GonzlezLpez2024,
  author = {González-López, Paula and Yu, Yinda and Lin, Shiying and Escribano, Óscar and Gómez-Hernández, Almudena and Gisterå, Anton},
  title = {Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression},
  journal = {Journal of Cardiovascular Translational Research},
  year = {2024},
  doi = {10.1007/s12265-024-10482-1}
}
Kostenlos starten →